The Filings Report

Viatris Inc. Common Stock

VTRSNasdaqCIK 1792044Healthcare / Drug Manufacturersfiscal year ends December29 quarters since 2019

Revenue, Q2 FY2026
$3.7B
+5.0% on Q2 FY2025
Net income
—
no year-earlier figure
Free cash flow
$329M
+97.2% on Q2 FY2025
Diluted EPS
$-0.10
no year-earlier figure
Revenue, TTM
$14.7B
trailing four quarters
Net margin, TTM
—
net income —
Free cash flow, TTM
$2.0B
$2.3B less $376M capex
Cash and equivalents
$887M
long-term debt $11.6B, Jun 30, 2026
Shares, 12-month change
−1.5%
1.15B shares, Jun 30, 2026
Buybacks, TTM
$303M
1.4% of market value
Dividends, TTM
—
no yield
Market value
$21.9B
at the close, buybacks

Latest quarter Q2 FY2026, filed August 6, 2026. Trailing figures sum the latest four quarters. Market values at the latest close, from a market data vendor.

In Q2 FY2026, the quarter ended June 30, 2026, Viatris Inc. Common Stock reported revenue of $3.7B, +5.0% on Q2 FY2025. Net income this quarter is driven by non-operating items: $50M of other income against $6M of operating income, so it reflects gains or losses outside the operations. Operating margin was 0.2%. Free cash flow, operating cash flow less capital expenditures, was $329M ($382M less $53M). Diluted earnings per share were $-0.10.

The last 16 quarters

Q3 FY2022 to Q2 FY2026, through the filing of August 6, 2026.

Revenue and net incomeRevenueNet income
$0$2B$4B$6BQ3'22, Revenue: $4.1BQ3'22Q4'22, Revenue: $3.9BQ4'22Q1'23, Revenue: $3.7BQ1'23Q2'23, Revenue: $3.9BQ2'23Q3'23, Revenue: $3.9BQ3'23Q4'23, Revenue: $3.8BQ4'23Q1'24, Revenue: $3.7BQ1'24Q2'24, Revenue: $3.8BQ2'24Q3'24, Revenue: $3.7BQ3'24Q4'24, Revenue: $3.5BQ4'24Q1'25, Revenue: $3.2BQ1'25Q2'25, Revenue: $3.6BQ2'25Q3'25, Revenue: $3.7BQ3'25Q4'25, Revenue: $3.7BQ4'25Q1'26, Revenue: $3.5BQ1'26Q2'26, Revenue: $3.7BQ2'26$0$2B$4B$6BQ3'22, Revenue: $4.1BQ4'22, Revenue: $3.9BQ4'22Q1'23, Revenue: $3.7BQ2'23, Revenue: $3.9BQ2'23Q3'23, Revenue: $3.9BQ4'23, Revenue: $3.8BQ4'23Q1'24, Revenue: $3.7BQ2'24, Revenue: $3.8BQ2'24Q3'24, Revenue: $3.7BQ4'24, Revenue: $3.5BQ4'24Q1'25, Revenue: $3.2BQ2'25, Revenue: $3.6BQ2'25Q3'25, Revenue: $3.7BQ4'25, Revenue: $3.7BQ4'25Q1'26, Revenue: $3.5BQ2'26, Revenue: $3.7BQ2'26

Net income losses drawn in red.

Free cash flow
$0$250M$500M$750M$1.0BQ3'22, Free cash flow: $765MQ3'22Q4'22, Free cash flow: $35MQ4'22Q1'23, Free cash flow: $923MQ1'23Q2'23, Free cash flow: $457MQ2'23Q3'23, Free cash flow: $739MQ3'23Q4'23, Free cash flow: $403MQ4'23Q1'24, Free cash flow: $565MQ1'24Q2'24, Free cash flow: $320MQ2'24Q3'24, Free cash flow: $750MQ3'24Q4'24, Free cash flow: $342MQ4'24Q1'25, Free cash flow: $493MQ1'25Q2'25, Free cash flow: $167MQ2'25Q3'25, Free cash flow: $658MQ3'25Q4'25, Free cash flow: $619MQ4'25Q1'26, Free cash flow: $348MQ1'26Q2'26, Free cash flow: $329MQ2'26$0$250M$500M$750M$1.0BQ3'22, Free cash flow: $765MQ4'22, Free cash flow: $35MQ4'22Q1'23, Free cash flow: $923MQ2'23, Free cash flow: $457MQ2'23Q3'23, Free cash flow: $739MQ4'23, Free cash flow: $403MQ4'23Q1'24, Free cash flow: $565MQ2'24, Free cash flow: $320MQ2'24Q3'24, Free cash flow: $750MQ4'24, Free cash flow: $342MQ4'24Q1'25, Free cash flow: $493MQ2'25, Free cash flow: $167MQ2'25Q3'25, Free cash flow: $658MQ4'25, Free cash flow: $619MQ4'25Q1'26, Free cash flow: $348MQ2'26, Free cash flow: $329MQ2'26

Operating cash flow less capital expenditures; negative quarters in red.

Cash and equivalents against long-term debtCash and equivalentsLong-term debt
$0$5B$10B$15B$20BQ3'22, Cash and equivalents: $647MQ3'22, Long-term debt: $18.7BQ3'22Q4'22, Cash and equivalents: $1.3BQ4'22, Long-term debt: $18.0BQ4'22Q1'23, Cash and equivalents: $507MQ1'23, Long-term debt: $18.1BQ1'23Q2'23, Cash and equivalents: $629MQ2'23, Long-term debt: $17.2BQ2'23Q3'23, Cash and equivalents: $1.3BQ3'23, Long-term debt: $17.1BQ3'23Q4'23, Cash and equivalents: $992MQ4'23, Long-term debt: $16.2BQ4'23Q1'24, Cash and equivalents: $1.0BQ1'24, Long-term debt: $16.1BQ1'24Q2'24, Cash and equivalents: $917MQ2'24, Long-term debt: $14.7BQ2'24Q3'24, Cash and equivalents: $1.9BQ3'24, Long-term debt: $14.3BQ3'24Q4'24, Cash and equivalents: $735MQ4'24, Long-term debt: $14.0BQ4'24Q1'25, Cash and equivalents: $755MQ1'25, Long-term debt: $14.2BQ1'25Q2'25, Cash and equivalents: $566MQ2'25, Long-term debt: $12.8BQ2'25Q3'25, Cash and equivalents: $975MQ3'25, Long-term debt: $12.5BQ3'25Q4'25, Cash and equivalents: $1.3BQ4'25, Long-term debt: $12.5BQ4'25Q1'26, Cash and equivalents: $1.8BQ1'26, Long-term debt: $12.4BQ1'26Q2'26, Cash and equivalents: $887MQ2'26, Long-term debt: $11.6BQ2'26$0$5B$10B$15B$20BQ3'22, Cash and equivalents: $647MQ3'22, Long-term debt: $18.7BQ4'22, Cash and equivalents: $1.3BQ4'22, Long-term debt: $18.0BQ4'22Q1'23, Cash and equivalents: $507MQ1'23, Long-term debt: $18.1BQ2'23, Cash and equivalents: $629MQ2'23, Long-term debt: $17.2BQ2'23Q3'23, Cash and equivalents: $1.3BQ3'23, Long-term debt: $17.1BQ4'23, Cash and equivalents: $992MQ4'23, Long-term debt: $16.2BQ4'23Q1'24, Cash and equivalents: $1.0BQ1'24, Long-term debt: $16.1BQ2'24, Cash and equivalents: $917MQ2'24, Long-term debt: $14.7BQ2'24Q3'24, Cash and equivalents: $1.9BQ3'24, Long-term debt: $14.3BQ4'24, Cash and equivalents: $735MQ4'24, Long-term debt: $14.0BQ4'24Q1'25, Cash and equivalents: $755MQ1'25, Long-term debt: $14.2BQ2'25, Cash and equivalents: $566MQ2'25, Long-term debt: $12.8BQ2'25Q3'25, Cash and equivalents: $975MQ3'25, Long-term debt: $12.5BQ4'25, Cash and equivalents: $1.3BQ4'25, Long-term debt: $12.5BQ4'25Q1'26, Cash and equivalents: $1.8BQ1'26, Long-term debt: $12.4BQ2'26, Cash and equivalents: $887MQ2'26, Long-term debt: $11.6BQ2'26

Positions at each quarter end, as filed; short-term investments are not included.

Income statement

Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.

Viatris Inc. Common Stock income statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 6, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025Q3 FY2024ended Sep 30, 2024filed Nov 7, 2024YoYQ2 FY2026vs Q2 FY2025
Revenue3,7463,5103,6913,7483,5693,2433,5153,738+5.0%
Cost of revenue2,3002,3602,5562,3882,2492,0932,3132,292+2.3%
Gross profit1,4571,1571,1481,3721,3331,1611,2151,459+9.3%
Research and development248249—250219222—198+13.5%
Selling, general and administrative1,1359291,0318879299481,0471,003+22.2%
Operating income6(80)(193)179233(2,882)(180)226−97.3%
Other income (expense)50(47)(31)(67)(333)(99)(226)10+115.1%
Pretax income(64)(247)(343)(8)(217)(3,097)(526)91+70.5%
Income tax55(424)(3)120(212)(55)(10)(4)+125.8%
Net income—————————
Diluted EPS ($)(0.10)0.15—(0.11)0.00(2.55)—0.08—
Diluted shares (millions)1,1631,175—1,1651,1731,192—1,200—

Fourth quarters are the fiscal year less the first nine months when the filer reports no discrete fourth quarter, and are marked. Diluted EPS is never derived, so a derived quarter shows none. Italic figures are derived.

Balance sheet

Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.

Viatris Inc. Common Stock balance sheet, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 6, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025Q3 FY2024ended Sep 30, 2024filed Nov 7, 2024YoYQ2 FY2026vs Q2 FY2025
Cash and equivalents8871,8041,3229755667557351,879+56.5%
Short-term investments——41———38——
Total current assets10,05610,9179,7899,9519,7759,6229,52111,308+2.9%
Total assets35,04536,83537,19337,92038,41238,47541,50144,754−8.8%
Total current liabilities6,3466,8107,0947,3647,1335,7205,7797,512−11.0%
Long-term debt11,61212,41412,48112,48812,79214,17814,03914,303−9.2%
Total liabilities20,78422,17722,48222,70322,84122,82522,86524,962−9.0%
Stockholders’ equity—————————
Shares outstanding (millions)1,1491,1651,1511,1521,1661,1741,1941,194—

Positions at each period end. Nothing on this statement is derived. Long-term debt is the filed noncurrent line only; no total-debt composite is constructed across filers. Italic figures are derived.

Cash flow statement

Last eight quarters, newest first, through Q2 FY2026 filed August 6, 2026.

Viatris Inc. Common Stock cash flow statement, quarterly
Millions of dollarsQ2 FY2026ended Jun 30, 2026filed Aug 6, 2026Q1 FY2026ended Mar 31, 2026filed May 7, 2026Q4 FY2025ended Dec 31, 2025filed Feb 26, 2026Q3 FY2025ended Sep 30, 2025filed Nov 6, 2025Q2 FY2025ended Jun 30, 2025filed Aug 7, 2025Q1 FY2025ended Mar 31, 2025filed May 8, 2025Q4 FY2024ended Dec 31, 2024filed Feb 27, 2025Q3 FY2024ended Sep 30, 2024filed Nov 7, 2024YoYQ2 FY2026vs Q2 FY2025
Operating cash flow382388816745220536483827+73.8%
Capital expenditures534019787534314077−0.2%
Free cash flow (CFO − capex)329348619658167493342750+97.2%
Depreciation and amortization672676767689678665746670−0.9%
Share repurchases1500856817517500−14.3%
Dividends paid—————————

10-Qs file cash flows as year-to-date totals, so quarterly figures are differenced from consecutive filings and marked. Free cash flow is operating cash flow less capital expenditures, computed from the two filed lines. Italic figures are derived.

Annual statements

Every fiscal year filed, newest first, through FY2025 filed February 26, 2026.

Income statement

Viatris Inc. Common Stock income statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Feb 27, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 27, 2023FY2021ended Dec 31, 2021filed Feb 28, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed May 7, 2020FY2018ended Dec 31, 2018filed Mar 1, 2021
Revenue14,25014,69315,38816,21817,81411,82011,37011,269
Cost of revenue9,2869,1168,9889,76612,3118,1497,6037,432
Gross profit5,0145,6246,4396,4975,5763,7973,8984,002
Research and development————751555640705
Selling, general and administrative3,7944,1054,0704,1794,5293,3452,5642,441
Operating income(2,663)107661,615(34)(211)716906
Other income (expense)(531)(83)101,7916(13)(44)(65)
Pretax income(3,665)(623)2032,813(664)(721)154298
Income tax(150)11148735605(51)138(54)
Net income————————
Diluted EPS ($)(3.00)(0.53)0.051.71(1.05)(1.11)0.030.68
Diluted shares (millions)——1,2071,2171,209601517517

Balance sheet

Viatris Inc. Common Stock balance sheet, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Feb 27, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 27, 2023FY2021ended Dec 31, 2021filed Feb 28, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed May 7, 2020FY2018ended Dec 31, 2018filed Mar 1, 2021
Cash and equivalents1,3227359921,260701844476388
Short-term investments413837353839——
Total current assets9,7899,52112,97610,63510,90312,8686,757—
Total assets37,19341,50147,68650,02254,84361,55331,256—
Total current liabilities7,0945,7797,7776,7469,88410,5635,569—
Long-term debt12,48114,03916,18818,01519,71722,42911,214—
Total liabilities22,48222,86527,21828,95034,35038,59919,372—
Stockholders’ equity——————0—
Shares outstanding (millions)1,1511,1941,1881,1971,2101,207——

Cash flow statement

Viatris Inc. Common Stock cash flow statement, annual
Millions of dollarsFY2025ended Dec 31, 2025filed Feb 26, 2026FY2024ended Dec 31, 2024filed Feb 27, 2025FY2023ended Dec 31, 2023filed Feb 28, 2024FY2022ended Dec 31, 2022filed Feb 27, 2023FY2021ended Dec 31, 2021filed Feb 28, 2022FY2020ended Dec 31, 2020filed Mar 1, 2021FY2019ended Dec 31, 2019filed May 7, 2020FY2018ended Dec 31, 2018filed Mar 1, 2021
Operating cash flow2,3162,3032,9002,9993,0171,2321,8042,342
Capital expenditures379326377406457243213252
Free cash flow (CFO − capex)1,9371,9772,5232,5932,5609891,5912,090
Depreciation and amortization2,7982,8932,7413,0284,5072,2162,0192,110
Share repurchases5012502500000432
Dividends paid————————

Insider activity

Form 4 filings by officers, directors and 10% owners, November 1, 2024 to November 1, 2026. Only open-market purchases and sales count as buys and sells; awards, exercises, tax withholding and gifts are listed in grey and never counted.

Bought, three months
$0
0 purchases by 0 insiders; officers and directors $0
Sold, three months
$0
0 sales by 0 insiders; officers and directors $0
Bought, twelve months
$2K
1 purchases by 1 insider; officers and directors $2K
Sold, twelve months
$1M
2 sales by 1 insider; officers and directors $1M

The last 25 transactions

TradedInsiderRoleTransactionSharesPriceValueHeld afterFiled
Aug 15, 2026Enrietti AndrewSee Remarksoption exercise25,134$0.00—244,811Aug 18, 2026
Aug 15, 2026Enrietti AndrewSee Remarkstax withholding10,931$16.23$177K233,880Aug 18, 2026
Aug 15, 2026Enrietti AndrewSee Remarksoption exercise999$0.00—234,879Aug 18, 2026
Aug 15, 2026Enrietti AndrewSee Remarkstax withholding435$16.23$7K234,444Aug 18, 2026
Jun 25, 2026Campbell PaulSee Remarksopen-market sale10b5-150,076$16.17$810K316,212Jun 26, 2026
Apr 15, 2026Le Goff CorinneChief Commercial Officeroption exercise39,344$0.00—122,558Apr 16, 2026
Apr 15, 2026Le Goff CorinneChief Commercial Officertax withholding17,450$13.86$242K105,108Apr 16, 2026
Apr 15, 2026Le Goff CorinneChief Commercial Officeroption exercise3,644$0.00—108,752Apr 16, 2026
Apr 15, 2026Le Goff CorinneChief Commercial Officertax withholding1,617$13.86$22K107,135Apr 16, 2026
Mar 23, 2026Campbell PaulSee Remarksopen-market sale21,350$13.28$284K366,288Mar 24, 2026
Mar 6, 2026Le Goff CorinneChief Commercial Officeroption exercise44,165$0.00—101,582Mar 10, 2026
Mar 6, 2026Le Goff CorinneChief Commercial Officeroption exercise2,193$0.00—84,187Mar 10, 2026
Mar 6, 2026Le Goff CorinneChief Commercial Officertax withholding19,588$14.16$277K81,994Mar 10, 2026
Mar 6, 2026Le Goff CorinneChief Commercial Officertax withholding973$14.16$14K83,214Mar 10, 2026
Mar 6, 2026Mistras TheodoraChief Financial Officertax withholding1,146$14.16$16K70,645Mar 10, 2026
Mar 6, 2026Mistras TheodoraChief Financial Officeroption exercise2,071$0.00—71,791Mar 10, 2026
Mar 6, 2026Mistras TheodoraChief Financial Officertax withholding23,067$14.16$327K69,720Mar 10, 2026
Mar 6, 2026Mistras TheodoraChief Financial Officeroption exercise41,711$0.00—92,787Mar 10, 2026
Mar 6, 2026Enrietti AndrewSee Remarkstax withholding415$14.16$6K219,677Mar 10, 2026
Mar 6, 2026Enrietti AndrewSee Remarkstax withholding8,337$14.16$118K219,140Mar 10, 2026
Mar 6, 2026Enrietti AndrewSee Remarksoption exercise952$0.00—220,092Mar 10, 2026
Mar 6, 2026Enrietti AndrewSee Remarksoption exercise19,169$0.00—227,477Mar 10, 2026
Mar 6, 2026Campbell PaulSee Remarksoption exercise1,371$0.00—388,239Mar 10, 2026
Mar 6, 2026Campbell PaulSee Remarkstax withholding601$14.16$9K387,638Mar 10, 2026
Mar 6, 2026Campbell PaulSee Remarksoption exercise27,603$0.00—398,956Mar 10, 2026

Full insider history for Viatris Inc. Common Stock, or insider activity across all companies. A record of filings, not a recommendation.

Tracked funds holding it

1 of the tracked managers held VTRS in their latest 13F filing, through August 14, 2026. Weight is the share of the fund’s reported portfolio. How the funds have traded VTRS by quarter.

FundManagerQuarterValueSharesWeightMove
Greenlight CapitalDavid EinhornQ2 2026$44M3M1.13%added +52.6%

Sources

Fiscal year ends in month 12; periods are labeled with the issuer's own fiscal calendar. Values are as most recently filed (restatements apply; per-share values are on current split basis per the connector's split table, flagged in adjusted). Flow items flagged in `derived` were computed (Q4 = FY − nine months; quarterly cash flow differenced from year-to-date filings) rather than read from a filing. `reconciliation.repaired` lists periods where a full-year figure was filed in a quarter slot: that row was dropped and the quarter rebuilt from the annual figure. `reconciliation.quarantined` lists periods where four filed quarters do not sum to the filed year — those quarterly values are withheld, so a blank there is a withholding rather than an absence of reporting.

Filer
VIATRIS INC., CIK 1792044 on EDGAR
Extract generated
November 1, 2026
Withheld
none
Repaired
2 quarters where a full-year figure was filed in a quarter slot and the quarter was rebuilt: other income FY2023, pretax income FY2023
XBRL concepts behind each line

Income statement

Revenue: RevenueFromContractWithCustomerExcludingAssessedTax
Cost of revenue: CostOfGoodsAndServicesSold
Gross profit: GrossProfit
Research and development: ResearchAndDevelopmentExpense
Selling, general and administrative: SellingGeneralAndAdministrativeExpense
Operating income: OperatingIncomeLoss
Other income (expense): OtherNonoperatingIncomeExpense
Pretax income: IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax: IncomeTaxExpenseBenefit
Net income: NetIncomeLoss
Diluted EPS ($): EarningsPerShareDiluted
Diluted shares (millions): WeightedAverageNumberOfDilutedSharesOutstanding

Balance sheet

Cash and equivalents: CashAndCashEquivalentsAtCarryingValue
Short-term investments: AvailableForSaleSecuritiesDebtSecuritiesCurrent
Total current assets: AssetsCurrent
Total assets: Assets
Total current liabilities: LiabilitiesCurrent
Long-term debt: LongTermDebtNoncurrent
Total liabilities: Liabilities
Stockholders’ equity: StockholdersEquity
Shares outstanding (millions): dei:EntityCommonStockSharesOutstanding

Cash flow statement

Operating cash flow: NetCashProvidedByUsedInOperatingActivities
Capital expenditures: PaymentsToAcquirePropertyPlantAndEquipment
Free cash flow (CFO − capex): not filed
Depreciation and amortization: DepreciationDepletionAndAmortization
Share repurchases: PaymentsForRepurchaseOfCommonStock
Dividends paid: PaymentsOfDividends

The data

The statements on this page as files, generated November 1, 2026.

JSON file
/data/financials/VTRS.json